Abbott and Sekisui announce an agreement to offer coagulation testing solutions for laboratories worldwide Read the full story

Zoetis announced an agreement to purchase animal health assets of Abbott for a purchase price of $255 million Read the full story

Abbott has entered into an acquisition agreement to purchase Topera. Read the full story

Advanced Biological Laboratories has granted Abbott non-exclusive rights to market ABL’s software suite for HIV genotyping data analysis. Read the full story

Banyan Biomarkers has licensed its intellectual property related to traumatic brain injury (TBI) biomarkers to Abbott for assessment and verification .

The terms of the in a pharma licensing agreement were not disclosed. Read the full story

Mylan, big pharma, will acquire Abbott's non-U.S. developed markets specialty and branded generics business ("the Assets") in an all-stock transaction. Read the full story

New Zealand’s Fonterra and Abbott, the US big pharma and health care giant are to develop a dairy farm hub in China. Read the full story

In today's m&a news, Abbott announced a definitive agreement to acquire Veropharm, a leading Russian pharmaceutical manufacturer. Read the full story

Abbvie is a global pharmaceutical company developing life saving products for a number of major diseases including immunology. Read the full story